ENDRA Life Sciences (NDRA) to Release Quarterly Earnings on Tuesday

ENDRA Life Sciences (NASDAQ:NDRA) is anticipated to post its Q1 2025 quarterly earnings results before the market opens on Tuesday, May 13th. Analysts expect ENDRA Life Sciences to post earnings of ($4.08) per share for the quarter.

ENDRA Life Sciences (NASDAQ:NDRA) last released its quarterly earnings results on Monday, March 31st. The company reported ($9.40) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($4.10) by ($5.30). On average, analysts expect ENDRA Life Sciences to post $-47 EPS for the current fiscal year and $-15 EPS for the next fiscal year.

ENDRA Life Sciences Trading Down 47.0 %

NASDAQ:NDRA opened at $3.26 on Friday. The stock has a 50 day moving average of $4.27 and a two-hundred day moving average of $5.25. ENDRA Life Sciences has a 12 month low of $2.90 and a 12 month high of $602.00. The firm has a market cap of $1.83 million, a P/E ratio of 0.00 and a beta of 0.19.

Analyst Upgrades and Downgrades

Separately, Ascendiant Capital Markets decreased their target price on shares of ENDRA Life Sciences from $75.00 to $50.00 and set a “buy” rating on the stock in a report on Monday, April 21st.

ENDRA Life Sciences Company Profile

ENDRA Life Sciences Inc develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion.